Largest biotech companies by total debt

Borrowings at the end of the latest fiscal year: long-term debt including the part due within a year, plus short-term borrowings. Leases are left out unless the company reports them in one figure with its debt.

Amgen leads the 11 biotech companies ranked by total debt, at HUF 18.33T, ahead of Gilead Sciences (HUF 8.37T) and Biogen (HUF 2.11T). Figures as of 18 Nov 2026, 23:26 UTC, from Yahoo Finance quotes.

Key facts

Companies ranked
11
First
AmgenHUF 18.33T
Median
HUF 198B
Combined market value
HUF 280.77T
Countries
5
Not ranked
13no total debt on file

Market values as of .

All countries
All sectors
Biotech
HUF
Clear filters
Largest biotech companies by total debt
#CompanyTotal debt ↓Market capPriceToday1 yearPrice, 30 daysCountry
1AmgenAMGN · Health CareHUF 18.33THUF 80.6THUF 149,000.56 3.07% down 34% up United States
2Gilead SciencesGILD · Health CareHUF 8.37THUF 70.35THUF 56,721.52 0.75% down 33% up United States
3BiogenBIIB · Health CareHUF 2.11THUF 12.47THUF 84,390.79 0.25% up 49% up United States
4Halozyme TherapeuticsHALO · Health CareHUF 719.2BHUF 3.67THUF 32,157.19 0.18% down 37% up United States
5QiagenQGEN · Health CareHUF 555.3BHUF 3.44THUF 16,635.81 0.38% down 12% up Netherlands
6ModernaMRNA · Health CareHUF 198BHUF 26.73THUF 66,056.50 4.84% down 755% up United States
7RepligenRGEN · Health CareHUF 182BHUF 3.71THUF 57,960.14 6.47% up 5% up United States
8Bio-TechneTECH · Health CareHUF 67.1BHUF 3.84THUF 24,419.99 0.17% up 26% up United States
9Adaptive BiotechnologiesADPT · Health CareHUF 44BHUF 1.55THUF 9,553.17 0.11% down 88% up United States
10Scholar Rock HoldingSRRK · Health CareHUF 33.5BHUF 1.97THUF 16,112.16 6.48% up 14% up United States
11CG OncologyCGON · Health CareHUF 1BHUF 2.4THUF 26,853.60 1.34% up 85% up United States

Sources: share prices and market values from Yahoo Finance; sector, country and category from each company's SEC registration; annual figures from the reports companies file with the SEC.

Market value is share price × shares outstanding, from Yahoo Finance; prices may be delayed 15 minutes or more and the ranking refreshes about every 20 minutes. The list covers companies with shares listed in the US, which includes foreign companies listed through ADRs but not ones listed only abroad. Sector, category and country come from each company's SEC registration. Total debt is from each company's latest annual report filed with the SEC (collected 2026-11-12); a company that reports in another currency is converted to US dollars at the exchange rate of that day, not of the period. Total debt is assembled from each company's debt lines and is the least complete of these figures: some companies tag part of their borrowings in ways it misses. Sums are converted from US dollars at today's exchange rate (1 USD = 335.7 HUF). 13 companies have no total debt on file and are not ranked here.

Questions and answers

Which biotech companies rank first by total debt?

Amgen (HUF 18.33T), Gilead Sciences (HUF 8.37T) and Biogen (HUF 2.11T) are the top three of the 11 biotech companies ranked by total debt as of 18 Nov 2026, 23:26 UTC.

How many biotech companies are in this ranking?

11 are ranked by total debt. 13 more have no total debt on file and are left out rather than ranked at zero.

What are these biotech companies worth together?

The 11 biotech companies ranked by total debt have a combined market value of HUF 280.77T as of 18 Nov 2026, 23:26 UTC.

What does ranking by total debt measure?

Borrowings at the end of the latest fiscal year: long-term debt including the part due within a year, plus short-term borrowings. Leases are left out unless the company reports them in one figure with its debt.

Cite this page

Funkfolio, “Largest biotech companies by total debt”, data as of 18 November 2026. https://funkfolio.com/companies/category/biotech?by=total-debt

Underlying data: Yahoo Finance; SEC EDGAR.